These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
58 related articles for article (PubMed ID: 18726321)
1. Combined therapy of p53-wt and drug in an orthotopic multidrug-resistant human lung cancer model. Gao Z; Gao Z; Zhang T Sci China C Life Sci; 1997 Jun; 40(3):232-7. PubMed ID: 18726321 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic effect of a retroviral wild-type p53 expression vector in an orthotopic lung cancer model. Fujiwara T; Cai DW; Georges RN; Mukhopadhyay T; Grimm EA; Roth JA J Natl Cancer Inst; 1994 Oct; 86(19):1458-62. PubMed ID: 8089864 [TBL] [Abstract][Full Text] [Related]
3. Prevention of orthotopic human lung cancer growth by intratracheal instillation of a retroviral antisense K-ras construct. Georges RN; Mukhopadhyay T; Zhang Y; Yen N; Roth JA Cancer Res; 1993 Apr; 53(8):1743-6. PubMed ID: 8467490 [TBL] [Abstract][Full Text] [Related]
4. Mutations in p53 cDNA sequence introduced by retroviral vector. Su S; Watanabe A; Yamamoto M; Nakajima E; Miyake K; Shimada T Biochem Biophys Res Commun; 2006 Feb; 340(2):567-72. PubMed ID: 16380088 [TBL] [Abstract][Full Text] [Related]
5. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53. Qazilbash MH; Xiao X; Seth P; Cowan KH; Walsh CE Gene Ther; 1997 Jul; 4(7):675-82. PubMed ID: 9282168 [TBL] [Abstract][Full Text] [Related]
6. A retroviral wild-type p53 expression vector penetrates human lung cancer spheroids and inhibits growth by inducing apoptosis. Fujiwara T; Grimm EA; Mukhopadhyay T; Cai DW; Owen-Schaub LB; Roth JA Cancer Res; 1993 Sep; 53(18):4129-33. PubMed ID: 8395976 [TBL] [Abstract][Full Text] [Related]
7. Retroviral vector-mediated transduction of K-ras antisense RNA into human lung cancer cells inhibits expression of the malignant phenotype. Zhang Y; Mukhopadhyay T; Donehower LA; Georges RN; Roth JA Hum Gene Ther; 1993 Aug; 4(4):451-60. PubMed ID: 8399492 [TBL] [Abstract][Full Text] [Related]
8. In situ generation of pseudotyped retroviral progeny by adenovirus-mediated transduction of tumor cells enhances the killing effect of HSV-tk suicide gene therapy in vitro and in vivo. Okada T; Caplen NJ; Ramsey WJ; Onodera M; Shimazaki K; Nomoto T; Ajalli R; Wildner O; Morris J; Kume A; Hamada H; Blaese RM; Ozawa K J Gene Med; 2004 Mar; 6(3):288-99. PubMed ID: 15026990 [TBL] [Abstract][Full Text] [Related]
9. [Effects of exogenous wild type p53 on malignant growth of human lung cancer cell line]. Wang H; Lai B; Li J Zhonghua Jie He He Hu Xi Za Zhi; 1998 May; 21(5):268-72. PubMed ID: 11326947 [TBL] [Abstract][Full Text] [Related]
10. High-efficiency gene transfer and high-level expression of wild-type p53 in human lung cancer cells mediated by recombinant adenovirus. Zhang WW; Fang X; Mazur W; French BA; Georges RN; Roth JA Cancer Gene Ther; 1994 Mar; 1(1):5-13. PubMed ID: 7621238 [TBL] [Abstract][Full Text] [Related]
11. Adenovirus-mediated tumor suppressor p53 gene therapy for anaplastic thyroid carcinoma in vitro and in vivo. Nagayama Y; Yokoi H; Takeda K; Hasegawa M; Nishihara E; Namba H; Yamashita S; Niwa M J Clin Endocrinol Metab; 2000 Nov; 85(11):4081-6. PubMed ID: 11095436 [TBL] [Abstract][Full Text] [Related]
12. Severe combined immunodeficiency (SCID) mouse modeling of P-glycoprotein chemosensitization in multidrug-resistant human myeloma xenografts. Bellamy WT; Odeleye A; Huizenga E; Dalton WS; Weinstein RS; Grogan TM Clin Cancer Res; 1995 Dec; 1(12):1563-70. PubMed ID: 9815957 [TBL] [Abstract][Full Text] [Related]
13. Increasing drug resistance in human lung cancer cells by mutant-type p53 gene mediated by retrovirus. Gao Z; Gao Z; Liu X; Zhang T Sci China C Life Sci; 1997 Feb; 40(1):101-6. PubMed ID: 18726304 [TBL] [Abstract][Full Text] [Related]
14. Wild type p53 increased chemosensitivity of drug-resistant human hepatocellular carcinoma Bel7402/5-FU cells. Li YX; Lin ZB; Tan HR Acta Pharmacol Sin; 2004 Jan; 25(1):76-82. PubMed ID: 14704126 [TBL] [Abstract][Full Text] [Related]
15. p53 alone or in combination with antisense cyclin D1 induces apoptosis and reduces tumor size in human melanoma. Sauter ER; Takemoto R; Litwin S; Herlyn M Cancer Gene Ther; 2002 Oct; 9(10):807-12. PubMed ID: 12224020 [TBL] [Abstract][Full Text] [Related]
16. Transcriptional suppression of multidrug resistance-associated protein (MRP) gene expression by wild-type p53. Wang Q; Beck WT Cancer Res; 1998 Dec; 58(24):5762-9. PubMed ID: 9865734 [TBL] [Abstract][Full Text] [Related]
17. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF-7/Adr human breast cancer cells. Ogretmen B; Safa AR Oncogene; 1997 Jan; 14(4):499-506. PubMed ID: 9053847 [TBL] [Abstract][Full Text] [Related]
18. d,l-buthionine-(S,R)-sulfoximine potentiates in vivo the therapeutic efficacy of doxorubicin against multidrug resistance protein-expressing tumors. Vanhoefer U; Cao S; Minderman H; Toth K; Skenderis BS; Slovak ML; Rustum YM Clin Cancer Res; 1996 Dec; 2(12):1961-8. PubMed ID: 9816155 [TBL] [Abstract][Full Text] [Related]
19. [The combination of recombinant rAd-p53 and adriamycin for management of primary drug resistance in chemotherapy of lung squamous cell cancer]. Du CH; Wu Z; Xu J Zhonghua Jie He He Hu Xi Za Zhi; 2006 Sep; 29(9):622-4. PubMed ID: 17129471 [TBL] [Abstract][Full Text] [Related]
20. Comparative study of p53 expression in human carcinoma cell lines A549 and MCF7 under anticancer drug treatment. Filyak OS; Stoika RS Ukr Biokhim Zh (1999); 2005; 77(2):136-40. PubMed ID: 16335246 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]